arginine has been researched along with Acute Myelogenous Leukemia in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (17.65) | 18.7374 |
1990's | 7 (20.59) | 18.2507 |
2000's | 2 (5.88) | 29.6817 |
2010's | 12 (35.29) | 24.3611 |
2020's | 7 (20.59) | 2.80 |
Authors | Studies |
---|---|
Almowaled, M; Barlow, J; Bartnik, A; Booth, S; Cheng, P; Craddock, C; De Santo, C; De Simone, D; Dunn, W; Endou, H; Fultang, L; Gneo, L; Jankevics, A; Keeshan, K; Lloyd, G; Mussai, F; Panetti, S; Platt, F; Potluri, S; Priestman, DA; Scarpa, U; Southam, A; Stavrou, V | 1 |
Cheng, Y; Huang, B; Jiang, JY; Li, MY; Li, SQ; Liu, J; Wang, XZ; Xu, S; Yao, FY; Zhang, N; Zhong, FM | 1 |
Gritsman, K | 1 |
Gorshkov, V; Grinev, V; Helin, K; Hendrickson, RC; Jensen, ON; Kovalchuk, S; Lorenzini, E; Radzisheuskaya, A; Shliaha, PV; Shlyueva, D | 1 |
Dirks, WG; Drexler, HG; Fähnrich, S; Hauer, V; Pommerenke, C; Quentmeier, H; Uphoff, CC; Zaborski, M | 1 |
Gusachenko, I; Lymanets, T; Maslova, G; Skrypnyk, I | 1 |
AlAbdi, L; Chen, T; Forstoffer, NE; Gowher, H; Liu, B; Michie, AR; Norvil, AB; Tu, YH | 1 |
Booth, S; Chesler, L; De Santo, C; Dunn, WB; Fultang, L; Jankevics, A; Lee, SP; Lloyd, G; Martins da Costa, B; Mussai, F; Panetti, S; Scarpa, U; Southam, A; Stavrou, V; Tubb, V; Yogev, O | 1 |
Bomalaski, JS; Chen, TY; Cho, SF; Feng, X; Hsiao, HH; Hsu, YT; Johnston, A; Kao, HW; Kuo, MC; Liu, TC; Liu, YC; Tsai, HJ | 1 |
Cai, Y; Chau, KC; Chow, DTL; Chow, JPH; Chung, SHK; Kwok, SY; Lam, JYT; Lee, WL; Leung, YC; Leung, YO; Lu, X; Wong, RMH; Yang, LL; Yuen, CH | 1 |
Biedroń, M; Butrym, A; Chachaj, A; Fleszar, MG; Gamian, A; Karczewski, M; Krzystek-Korpacka, M; Mazur, G; Rybka, J; Szuba, A; Wiśniewski, J; Wróbel, T | 1 |
Abi-Habib, RJ; Bekdash, A; Frankel, AE; Georgiou, G; Kassab, E; Stone, E; Tanios, R | 1 |
Bari, R; Gan, K; Kang, G; Leung, W; Rujkijyanont, P; Sullivan, E; Turner, V | 1 |
Gao, C; Gao, L; Guan, L; Li, M; Wang, L; Yin, Y; Yu, L | 1 |
Beggs, A; Cheng, P; De Santo, C; Egan, S; Higginbotham-Jones, J; Kearns, P; Lo, A; Loke, J; Mussai, F; Ng, M; Odintsova, E; Perry, T; Pratt, G; U, KP | 1 |
Anjos-Afonso, F; Ariza-McNaughton, L; Bomalaski, JS; Bonnet, D; Cavenagh, J; Clear, A; Ghazaly, E; Grantham, M; Gribben, JG; Hodby, KA; Liapis, K; Miraki-Moud, F; Sohrabi, F; Szlosarek, PW; Taussig, DC | 1 |
Alinari, L; Anghelina, M; Baiocchi, RA; Caligiuri, MA; Croce, CM; Frankhouser, D; Garzon, R; Huang, X; Lai, H; Li, C; Li, L; Marcucci, G; Radomska, HS; Santhanam, R; Tarighat, SS; Walker, A; Wang, H | 1 |
Abdel-Wahab, O; Chen, WY; Chrysovergis, K; Lu, R; Parton, T; Rockowitz, S; Wade, PA; Wang, GG; Wang, P; Zheng, D; Zhou, Y | 1 |
Hämäläinen, S; Jantunen, E; Juutilainen, A; Koivula, I; Lappalainen, M; Pulkki, K | 1 |
Jing, N; Shao, H; Tweardy, DJ; Xu, X | 1 |
Doppler, W; Fuchs, D; Goossen, B; Grünewald, K; Hentze, MW; Pantopoulos, K; Wachter, H; Weiss, G; Werner-Felmayer, G | 1 |
Hansz, J | 1 |
Kass, L | 1 |
Becker, Y; Haspel, O; Kotler, M; Olshevsky, U; Weinberg, E | 1 |
Higashino, K; Izumi, K; Kobayashi, S; Kodama, J; Satani, M | 1 |
Hirschfeld, S; Ho, PT; Pazdur, R; Smith, M | 1 |
Crist, WM; Pratt, CB; Pui, CH; Rivera, GK; Santana, VM | 1 |
Herngren, L; Liliemark, E; Liliemark, J; Peterson, C; Pettersson, B | 1 |
Sullivan, MP; Sutow, WW | 1 |
Anderson, GR; Beerman, TA; Russo, CA; Spina, AM; Stoler, DL | 1 |
Castel, V; Esquembre, C; Fernandez, JM; Ferris, J; Prieto, F; Ruiz, JG; Tasso, MJ; Verdeguer, A | 1 |
Evans, WE; Mirro, J; Petros, WP; Rodman, JH | 1 |
Björkholm, M | 1 |
Dahl, GV; Grier, HE; Kalwinsky, DK; Mason, C; Mirro, J; Murphy, SB; Santana, VM | 1 |
3 review(s) available for arginine and Acute Myelogenous Leukemia
Article | Year |
---|---|
Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives.
Topics: Antineoplastic Agents; Azacitidine; Child; Child, Preschool; Drug Approval; Humans; Leukemia, Myeloid, Acute; Methotrexate; Neuroblastoma; Osteosarcoma; Pediatrics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide; United States; United States Food and Drug Administration; Vindesine | 2003 |
Epipodophyllotoxins in the treatment of childhood cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Neoplasms; Neoplasms, Second Primary; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1994 |
Etoposide and teniposide in the treatment of acute leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1990 |
1 trial(s) available for arginine and Acute Myelogenous Leukemia
Article | Year |
---|---|
Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinate Synthase; Cytarabine; Drug Administration Schedule; Female; Humans; Hydrolases; Injections, Intramuscular; Injections, Subcutaneous; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Polyethylene Glycols; Thrombocytopenia; Treatment Outcome | 2021 |
30 other study(ies) available for arginine and Acute Myelogenous Leukemia
Article | Year |
---|---|
Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment.
Topics: Arginine; Cell Proliferation; Humans; Leukemia, Myeloid, Acute; Myeloid-Derived Suppressor Cells; Natural Killer T-Cells | 2023 |
Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia.
Topics: Alternative Splicing; Arginine; Cell Cycle Proteins; Humans; Leukemia, Myeloid, Acute; Prognosis; Repressor Proteins; RNA Splicing; RNA Splicing Factors; Serine-Arginine Splicing Factors; Tumor Microenvironment | 2023 |
FLT3-ITD gets by with a little help from PRMT1.
Topics: Arginine; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Methylation; Methyltransferases; Mutation; Protein-Arginine N-Methyltransferases; Repressor Proteins | 2019 |
PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia.
Topics: Animals; Antineoplastic Agents; Arginine; Catalysis; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Methylation; Mice; Molecular Targeted Therapy; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Oncogene Proteins, Fusion; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Proteomics; RNA Splicing; Serine-Arginine Splicing Factors | 2019 |
DNMT3A R882H mutation in acute myeloid leukemia cell line SET-2.
Topics: Amino Acid Substitution; Arginine; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; DNA Mutational Analysis; Histidine; Humans; Leukemia, Myeloid, Acute; Mutation, Missense | 2020 |
How to improve quality of life in patients with acute leukemia and comorbid ischemic heart disease treated with anthracycline-based induction chemotherapy.
Topics: Adult; Anthracyclines; Antibiotics, Antineoplastic; Arginine; Cardiotoxicity; Comorbidity; Cryoprotective Agents; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Myocardial Ischemia; Quality of Life | 2019 |
The acute myeloid leukemia variant DNMT3A Arg882His is a DNMT3B-like enzyme.
Topics: Amino Acid Substitution; Animals; Arginine; CpG Islands; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; DNA, Satellite; Embryonic Stem Cells; Humans; Kinetics; Leukemia, Myeloid, Acute; Mice; Mutation; Myeloid Ecotropic Viral Integration Site 1 Protein; Substrate Specificity | 2020 |
Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity.
Topics: Animals; Apoptosis; Arginine; Argininosuccinate Synthase; Cell Proliferation; Humans; Immunotherapy, Adoptive; Leukemia, Myeloid, Acute; Metabolic Engineering; Mice; Mice, Nude; Neuroblastoma; Ornithine Carbamoyltransferase; Receptors, Chimeric Antigen; T-Lymphocytes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
NEI-01-Induced Arginine Deprivation Has Potent Activity Against Acute Myeloid Leukemia Cells Both
Topics: Animals; Arginine; Disease Models, Animal; Humans; Hypothalamic Hormones; Leukemia, Myeloid, Acute; Mice; Peptide Fragments | 2021 |
Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers, Tumor; Case-Control Studies; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Prospective Studies; Survival Rate; Young Adult | 2018 |
Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells.
Topics: Apoptosis; Arginase; Arginine; Argininosuccinate Synthase; Autophagy; Blotting, Western; Cell Cycle; Cell Proliferation; Flow Cytometry; Humans; Leukemia, Myeloid, Acute; Polyethylene Glycols; Recombinant Proteins; Tumor Cells, Cultured | 2013 |
Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation.
Topics: Adolescent; Alleles; Analysis of Variance; Arginine; Child; Child, Preschool; Cysteine; Disease Progression; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; HLA-C Antigens; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, KIR2DL1; Transplantation, Homologous | 2013 |
The Frequency and clinical significance of IDH1 mutations in Chinese acute myeloid leukemia patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Asian People; Child; Female; Humans; Isocitrate Dehydrogenase; Karyotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation Rate; Survival Analysis | 2013 |
Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.
Topics: Adolescent; Aged; Animals; Antimetabolites, Antineoplastic; Arginase; Arginine; Child; Child, Preschool; Cytarabine; Enzyme Therapy; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mice, SCID; Middle Aged; Recombinant Proteins; Tumor Cells, Cultured; Young Adult | 2015 |
Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo.
Topics: Animals; Antineoplastic Agents; Arginine; Argininosuccinate Synthase; Blotting, Western; Cells, Cultured; Chromatography, High Pressure Liquid; Humans; Hydrolases; Immunohistochemistry; Leukemia, Myeloid, Acute; Mass Spectrometry; Mice; Mice, Inbred NOD; Mice, SCID; Polyethylene Glycols; Real-Time Polymerase Chain Reaction; Xenograft Model Antitumor Assays | 2015 |
The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.
Topics: Animals; Apoptosis; Arginine; Blotting, Western; Cell Proliferation; Chromatin Immunoprecipitation; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Epigenomics; Flow Cytometry; Gene Expression Regulation, Leukemic; Histones; Humans; Immunoenzyme Techniques; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, SCID; MicroRNAs; Protein-Arginine N-Methyltransferases; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Transcriptional Activation; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |
Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development.
Topics: Animals; Arginine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Genes, ras; Homeodomain Proteins; Humans; Leukemia, Myeloid, Acute; Methyltransferases; Mice; Mutation; Myeloid Ecotropic Viral Integration Site 1 Protein; Neoplasm Proteins; Neoplasms, Experimental; Promoter Regions, Genetic; Stem Cells; Tumor Cells, Cultured | 2016 |
Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Arginine; Bacteremia; Biomarkers; C-Reactive Protein; Febrile Neutropenia; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prospective Studies; Shock, Septic; Stem Cell Transplantation; Transplantation, Autologous | 2017 |
Unique structural determinants for Stat3 recruitment and activation by the granulocyte colony-stimulating factor receptor at phosphotyrosine ligands 704 and 744.
Topics: Arginine; Cell Line; Computational Biology; Glutamic Acid; Humans; Leukemia, Myeloid, Acute; Ligands; Lysine; Models, Molecular; Phosphopeptides; Phosphotyrosine; Protein Binding; Receptors, Granulocyte Colony-Stimulating Factor; STAT3 Transcription Factor | 2006 |
Stimulation of IRE-BP activity of IRF by tetrahydrobiopterin and cytokine dependent induction of nitric oxide synthase.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Biopterins; Cell Line; Chloramphenicol O-Acetyltransferase; Deferoxamine; Humans; Interferon-gamma; Iron; Iron-Regulatory Proteins; Kinetics; Leukemia, Myeloid, Acute; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; RNA Probes; RNA-Binding Proteins; Transfection; Tumor Cells, Cultured | 1994 |
[Metabolic utilization of arginine by leukemic cells in acute myeloid leukemia].
Topics: Adolescent; Adult; Arginine; Blood Proteins; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged | 1979 |
Histone abnormalities in adult acute leukemias.
Topics: Adult; Arginine; Electrophoresis, Disc; Esterases; Hematopoietic Stem Cells; Histones; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lysine; Monocytes | 1975 |
Particles released from arginine deprived human leukaemic cells.
Topics: Arginine; Cells, Cultured; Centrifugation, Density Gradient; Culture Media; DNA, Viral; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocytes; Microscopy, Electron; Oncogenic Viruses; Ribonucleases; RNA-Directed DNA Polymerase; RNA, Ribosomal; Templates, Genetic; Tritium; Uridine; Virus Cultivation | 1973 |
[Developing mechanism of the adverse effects of L-asparaginase and their control].
Topics: Ammonia; Arginine; Asparaginase; Glutamates; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Nausea; Renal Dialysis; Seizures; Shock; Unconsciousness; Vomiting | 1974 |
Ultrafiltration and subsequent high performance liquid chromatography for in vivo determinations of the protein binding of etoposide.
Topics: Antineoplastic Agents; Blood Proteins; Chromatography, High Pressure Liquid; Dialysis; Etoposide; Humans; Leukemia, Myeloid, Acute; Reference Values; Teniposide; Ultrafiltration | 1996 |
Childhood cancer: the improving prognosis.
Topics: Asparaginase; Child; Cyclophosphamide; Cytosine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Melphalan; Mercaptopurine; Methotrexate; Neoplasms; Nitrogen Mustard Compounds; Osteosarcoma; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Rhabdomyosarcoma; Teniposide; Thioguanine; Vincristine; Wilms Tumor | 1976 |
Anoxia-inducible endonuclease activity as a potential basis of the genomic instability of cancer cells.
Topics: Animals; Cell Hypoxia; Cell Survival; DNA Probes; DNA, Neoplasm; Endonucleases; Enzyme Induction; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Liver Neoplasms, Experimental; Molecular Weight; Neoplasms; Plasmids; Rats; Teniposide; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1992 |
Acute nonlymphoblastic leukemia in children treated for acute lymphoblastic leukemia with an intensive regimen including teniposide.
Topics: Child, Preschool; Female; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1992 |
Pharmacokinetics of continuous-infusion amsacrine and teniposide for the treatment of relapsed childhood acute nonlymphocytic leukemia.
Topics: Adolescent; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Humans; Infant; Leukemia, Myeloid, Acute; Teniposide | 1991 |
Effective reinduction therapy for childhood acute nonlymphoid leukemia using simultaneous continuous infusions of teniposide and amsacrine.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukopenia; Male; Mouth Mucosa; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Stomatitis; Teniposide; Thrombocytopenia | 1989 |